NEW YORK (GenomeWeb News) – Knome and Personal Genomics today announced an exclusive sales agreement and a scientific partnership covering Knome's knoSys platform.

Personal Genomics, based in Verona, Italy, becomes Knome's first international distributor, Personal Genomics CEO Marco Dotto said in a statement. Additionally, his firm will continue developing tools, content, and applications for knoSys, which is used for managing and interpreting sequencing data. The platform combines analytical and workflow software with grid computers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.